Gerresheimer (GRRMF) Projected to Release Earnings on Wednesday

Gerresheimer (OTCMKTS:GRRMF) is expected to be issuing its results before the market opens on Wednesday, September 16th. Analysts expect Gerresheimer to post earnings of $0.2854 per share and revenue of $694.4810 million for the quarter.

Gerresheimer Stock Performance

Shares of Gerresheimer stock opened at $32.20 on Tuesday. The stock’s 50 day simple moving average is $31.83 and its 200-day simple moving average is $28.11. Gerresheimer has a 1-year low of $19.16 and a 1-year high of $33.35.

Wall Street Analyst Weigh In

A number of research firms have weighed in on GRRMF. Sanford C. Bernstein raised Gerresheimer from an “underperform” rating to a “market perform” rating in a research note on Wednesday, July 1st. UBS Group upgraded Gerresheimer from a “sell” rating to a “neutral” rating in a report on Tuesday, August 4th. Jefferies Financial Group cut shares of Gerresheimer to a “hold” rating in a research report on Monday, May 18th. Finally, Deutsche Bank Aktiengesellschaft reissued a “hold” rating on shares of Gerresheimer in a report on Tuesday, August 4th. Four analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Reduce”.

Gerresheimer Company Profile

Gerresheimer AG is a Germany-based healthcare company that develops and manufactures specialty packaging and drug-delivery systems for the pharmaceutical, biotech and cosmetics industries. Its products are designed to protect, store and administer medicines and other sensitive healthcare products.

The company’s portfolio includes glass and plastic containers such as vials, ampoules, bottles and syringes, as well as prefillable syringes, cartridges, inhalers, injection pens and other delivery devices.